Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Nano-Curcumin in Juvenile Idiopathic Arthritis
IRCT20191221045837N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in juvenile idiopathic arthritis (JIA), sponsored by Mashhad University of Medical Sciences. Started Oct 2020; status: completed.
02
Drugs
curcumin
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on IRCT20191221045837N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191221045837N1.